Cargando…
Drug switching in the Netherlands: a cohort study of 20 active substances
BACKGROUND: For a patient, drug switches are not desirable (either between a brand-name drug and a generic drug, or between two generic drugs of the same active substance). Research into the causes of drug switches, and related adverse drug reactions, is hampered by the absence of quantitative data...
Autores principales: | Glerum, Pieter J., Maliepaard, Marc, de Valk, Vincent, Burger, David M., Neef, Kees |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359503/ https://www.ncbi.nlm.nih.gov/pubmed/32660480 http://dx.doi.org/10.1186/s12913-020-05494-x |
Ejemplares similares
-
Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands
por: Glerum, Pieter J., et al.
Publicado: (2020) -
Pharmacokinetics and Generic Drug Switching: A Regulator’s View
por: Glerum, Pieter J., et al.
Publicado: (2020) -
Interchangeability of Generic Drugs: A Nonparametric Pharmacokinetic Model of Gabapentin Generic Drugs
por: Glerum, Pieter J., et al.
Publicado: (2018) -
Investigation into the interchangeability of generic formulations using immunosuppressants and a broad selection of medicines
por: Yu, Yang, et al.
Publicado: (2015) -
COVID-19 in people with HIV in the Netherlands
por: Wit, Ferdinand W.N.M., et al.
Publicado: (2023)